Cargando…
Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer
INTRODUCTION: Available guidelines are inconsistent as to whether patients with newly diagnosed clinical stage II NSCLC should receive routine brain imaging. METHODS: The National Cancer Database was queried for the prevalence of isolated brain metastases among patients with newly diagnosed NSCLC in...
Autores principales: | Pichert, Matthew D., Canavan, Maureen E., Maduka, Richard C., Li, Andrew X., Ermer, Theresa, Zhan, Peter L., Kaminski, Michael, Udelsman, Brooks V., Blasberg, Justin D., Mase, Vincent J., Dhanasopon, Andrew P., Boffa, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079298/ https://www.ncbi.nlm.nih.gov/pubmed/35540711 http://dx.doi.org/10.1016/j.jtocrr.2022.100318 |
Ejemplares similares
-
Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022) -
Assessment of a collaborative treatment model for trimodal management of esophageal cancer
por: Udelsman, Brooks V., et al.
Publicado: (2023) -
Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
por: Zhan, Peter L., et al.
Publicado: (2022) -
Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US
por: Ermer, Theresa, et al.
Publicado: (2022) -
Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)